Elevated serum concentration of interleukin-1 receptor antagonist (IL- 1ra) is correlated to interleukin-6 and to hypoalbuminemia in cachectic patients with colorectal cancer

International Journal of Clinical Oncology

Volumn 5, Issue 2, 2000, Pages 116-120

  Shibata, Masahiko ^a   Nagata, Yasuhiko ^a   Kimura, Tomo ^a   Kanou, Hisao ^a   Nezu, Takeshi ^a   Takekawa, Motoo ^a   Fukuzawa, Masahiro ^a  

^a NIHON UNIVERSITY   (Japan)

Author keywords

Cachexia; Colorectal cancer; Interleukin 1 receptor antagonist; Interleukin 6

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 6;

ARTICLE; CACHEXIA; CLINICAL ARTICLE; COLON CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HYPOALBUMINEMIA; IMMUNOREGULATION; NUTRITION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

EID: 0034034814     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/s101470050101     Document Type: Article

References (25)

1. Tessitore L, Costelli P, Baccino FM (1993) Humoral mediation for cancer cachexia in tumour-bearing rats. Br J Cancer 67:15-23
2. Lawson DH, Richmond A, Nixon DW, Rudman D (1982) Metabolic approaches to cancer cachexia. Annu Rev Nutr 2:277-301
3. Morrison SD (1989) Cancer cachexia. In: Liotta AL (ed) Influence of tumor development on the host. Kluwer, Dordrecht, pp 176-213
4. Dinarello CA (1991) Interleukin-1 and interleukin-1 antagonism. Blood 77:1627-1652
5. Arend WP, Joslin FG, Massoni RJ (1985) Effects of immune complexes on production by human monocytes of interleukin-1 or an interleukin-1 inhibitor. J Immunol 134:3868-3874
6. Seckinger P, Lowenthal JW, Williamson K, et al. (1987) A urine inhibitor of interleukin-1 activity that blocks ligand binding. J Immunol 139:1546-1554
7. Eisenberg SP, Evans RJ, Arend WP, et al. (1990) Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature 343:341-342
8. Dinarello CA, Thompson RC (1991) Blocking of IL-1: interleukin-1 receptor antagonist in vivo and in vitro. Immunol Today 12:404-407
9. Arend WP (1991) Interleukin-1 receptor antagonist. A new member of the interleukin-1 family. J Clin Invest 88:1445-1452
10. Baracos V, Rodeman P, Dinarello CA, Goldberg AL (1983) Stimulation of muscle protein degradation and prostaglandin E2 release by leukocyte pyrogen (interleukin-1). N Engl J Med 308:553-558
11. Goldberg AL, Kettelhut K, Fagan J, Baracos V (1988) Activation protein breakdown and prostaglandin E2 production in rat skeletal muscle in fever is signaled by a macrophage product distinct from interleukin-1 or other known monokines. J Clin Invest 81:1378-1383
12. Fong Y, Moldawer LL, Marano M, et al. (1989) Cachectin/TNF or IL-1a induces cachexia with redistribution of body proteins. Am J Physiol 256:R659-R665
13. Moldawer LL, Drott C, Lundholm K (1988) Monocytic production and plasma bioactivities of interleukin-1 and tumor necrosis factor in human cancer. Eur J Clin Invest 18:486-492
14. Carter DB, Deibel MR, Dunn CJ, et al. (1990) Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein. Nature 344:633-638
15. McIntyre KW, Stephan GJ, Kolinsky KD, et al. (1991) Inhibition of interleukin-1 binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and IL-1 receptor monoclonal antibody. J Exp Med 173:931-939
16. Vidal-Vanaclocha F, Amezaga C, Asumendi A, et al. (1993) Interleukin-1 receptor antagonist (IL-1ra) inhibits hepatic metastasis of intrasplenically injected B 16 melanoma cells. In: Proceedings of the 84th Annual Meeting of the American Association of Cancer Research, Orlando, FL. Cadmus Journal Services, Linthicum, MD, p 73
17. Filgueria L, Zuber M, Merlo A (1993) Cytokine gene transcription in renal cell carcinoma. Br J Surg 80:1322-1325
18. Gastl GA, Abrams JS, Nanus DM, et al. (1993) Interkeukin-10 production by human carcinoma cell lines and its relationship to interleukin-6 expression. Int J Cancer 55:96-101
19. Pisa P, Halapi E, Pisa EK (1992) Selective expression of interleukin-10, interferon gamma, and granulocyte-macrophage colony-stimulating factor in ovarian cancer biopsies. Proc Natl Acad Sci USA 89:7708-7712
20. Moldawer LL, Georgieff M, Lundholm K (1987) Interleukin-1, tumor necrosis factor alpha and the pathogenesis of cancer cachexia. Clin Physiol 7:236-237
21. Lonnroth C, Moldawer LL, Gelin J, et al. (1990) Tumor necrosis factor alpha and interleukin-1 alpha production in cachexic, tumor-bearing mice. Int J Cancer 46:889-896
22. Oliff A (1988) The role of tumor necrosis factor (cachectin) in cachexia. Cell 54:141-151
23. Beutler B, Greenwalt D, Humes JD (1985) Identity of tumor necrosis factor and the macrophage-secreted factor cachectin. Nature 316:552-555
24. Cerami A, Ikeda Y, Le Trang N (1985) Weight loss associated with an endotoxin-induced mediator from peritoneal macrophages: the role of cachectin (tumor necrosis factor). Immunol Lett 11:173-181
25. Langstein HN, Doherty GM, Fraker DL, et al. (1991) The roles of gamma interferon and tumor necrosis factor alpha in an experimental rat model of cancer cachexia. Cancer Res 51:2302-2311